Related Experiment Video
Updated: Jun 3, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Prevalence and Risk Factors of Cognitive Impairment in COPD: A Systematic Review and Meta-Analysis
Ziwei Zhang1,2, Pengyu Yang3, Gui Xiao4
1Department of Gastrointestinal Surgery, Peking University Shenzhen Hospital, Shenzhen, China.
Cognitive impairment (CI) affects 20-30% of patients with chronic obstructive pulmonary disease (COPD). Key risk factors include cough, FEV1, age, and depression, highlighting the need for early screening and intervention in COPD management.
Area of Science:
- Pulmonary Medicine
- Neurology
- Epidemiology
Background:
- Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that can affect multiple organs.
- Hypoxia in COPD is linked to cognitive impairment (CI), a condition often overlooked in clinical assessments.
- Mild cognitive impairment (MCI) may precede dementia and represents a potential window for intervention.
Purpose of the Study:
- To systematically review and meta-analyze the pooled prevalence of cognitive impairment (CI) and mild cognitive impairment (MCI) in patients with COPD.
- To identify and evaluate the key risk factors associated with the development of CI in the COPD population.
Main Methods:
- A comprehensive systematic review and meta-analysis of cohort, case-control, and cross-sectional studies.
- Searched major databases (PubMed, Web of Science, Cochrane Library, etc.) up to June 2023.
- Employed random-effects models for prevalence and risk factor estimation, with quality assessed by NOS and AHRQ criteria.
Main Results:
- Included 41 studies with 138,030 participants; pooled prevalence of CI was 20-30% and MCI was 24%.
- Significant heterogeneity was observed (I² > 90%), with geographical region identified as a source.
- Identified influential factors for CI in COPD: cough, FEV1, PaO₂, age, education, depression, and BODE index.
Conclusions:
- The prevalence of CI in COPD patients shows an increasing trend, varying by region and assessment tools.
- Specific factors like cough, lung function (FEV1), oxygen levels (PaO₂), age, education, depression, and BODE index significantly influence CI development.
- Recommends early screening and targeted interventions for CI in COPD patients to mitigate incidence and improve outcomes.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

